Associated Papers
Beyond MEN1, When to Think About MEN4? Retrospective Study on 5600 Patients in the French Population and Literature Review.
Chevalier B et al.
The Journal of Clinical Endocrinology and Metabolism, 2024
Novel germline variants of CDKN1B and CDKN2C identified during screening for familial primary hyperparathyroidism.
Mazarico-Altisent I et al.
Journal of Endocrinological Investigation, 2023
36334246 (PubMed )
Supplement: 40618_2022_1948_MOESM1_ESM.xlsx › Supplementary_material
Multiple endocrine neoplasia type 4: a new member of the MEN family.
Singeisen H et al.
Endocrine Connections, 2023
Case Report: New CDKN1B Mutation in Multiple Endocrine Neoplasia Type 4 and Brief Literature Review on Clinical Management.
Lavezzi E et al.
Frontiers in Endocrinology, 2022
HEREDITARY PITUITARY TUMOR SYNDROMES: GENETIC AND CLINICAL ASPECTS.
García-Guzmán B et al.
Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion, 2020
Clinical Features of Multiple Endocrine Neoplasia Type 4: Novel Pathogenic Variant and Review of Published Cases.
Frederiksen A et al.
The Journal of Clinical Endocrinology and Metabolism, 2019
Select a paper to view details